Concepedia

Elizabeth S. Chlipala

ES

3

Publications

221

Citations

3

H-Index

1999

Active since

Affiliations

Amgen (United States)(Current)

University of Colorado Boulder

Elizabeth S. Chlipala is an author at Amgen (United States) specializing in autoimmune disease, inflammation, and chronic inflammation.

Top concepts

Publications per year

1999–2006

3

Publications

3

Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis

Alison M. Bendele, Elizabeth S. Chlipala, J Scherrer et al. · Arthritis & Rheumatism · 2000 · 164 citations

Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor α

Carl K. Edwards, Alison M. Bendele, Leonid I. Reznikov et al. · Arthritis & Rheumatism · 2006 · 32 citations

Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats

A.M. Bendele, Jennifer McComb, T. Gould et al. · Inflammation Research · 1999 · 25 citations

, , +12

Rows per page

1–3 of 3